Cardiac overexpression of type2 AngiotensinII receptor in transgenic mice attenuates cardiac fibrosis but not cardiac hypertrophy

被引：0
|
作者：
Kurisu, S
Sugino, H
Ozono, R
Oshima, T
Matsuura, H
Teranishi, Y
Masayuki, K
Kajiyama, G
Masaki, H
Mori, Y
Matsubara, H
机构：
[1] Hiroshima Univ, Hiroshima, Japan
[2] Kansai Med Sch, Osaka, Japan
来源：
HYPERTENSION | 1999年 / 34卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
21
引用
收藏
页码：331 / 331
页数：1
相关论文
共 50 条
  • [21] Cardiac-specific overexpression of AT1 receptor mutant lacking Gαq/Gαi coupling causes cardiac hypertrophy and bradycardia in transgenic mice
    Zhai, PY
    Galeotti, J
    Liu, J
    Yamamoto, M
    Sadoshima, J
    CIRCULATION, 2004, 110 (17) : 155 - 156
  • [22] KLF15 negatively regulates cardiac fibrosis by which SDF-1β attenuates cardiac fibrosis in type 2 diabetic mice
    Tian, Yuanyuan
    Wang, Zhenyu
    Zheng, Xiangyu
    Song, Wenjing
    Cai, Lu
    Rane, Madhavi
    Zhao, Yuguang
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021, 427
  • [23] Homozygous transgenic mice overexpressing cardiac NCX1.1 develop cardiac hypertrophy
    Iwamoto, T
    Kita, S
    Arai, Y
    Takamatsu, H
    Adachi-Akahane, S
    Katsuragi, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 150P - 150P
  • [24] Transgenic mice with cardiac-specific angiotensinogen overexpression
    Pedrazzini, T
    Mazzolai, L
    Aubert, JF
    Nussberger, J
    HYPERTENSION, 1996, 28 (04) : 708 - 708
  • [25] Cardiac myocyte apoptosis and LV remodeling in transgenic mice with cardiac restricted overexpression of TNF
    Engel, DJ
    Sivasubramanian, N
    Mann, DL
    CIRCULATION, 1999, 100 (18) : 206 - 206
  • [26] Cardiac-Restricted Overexpression of Liver X Receptor Attenuates Adverse Cardiac Remodeling
    Cannon, Megan V.
    Sillje, Herman H.
    van Genne, Linda
    Vreeswijk-Baudoin, Inge
    van Gilst, Wiek H.
    De Boer, Rudolf A.
    CIRCULATION, 2011, 124 (21)
  • [27] Severe Cardiac Hypertrophy and Depressed Contractility in Transgenic Mice with Co-Overexpression of Calsequestrin and SERCA2a
    Kirchhefer, Uwe
    Baba, Hideo A.
    Jones, Larry R.
    Neumann, Joachim
    Schmitz, Wilhelm
    Mueller, Frank U.
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 554A - 555A
  • [28] Cardiac-specific overexpression of human phospholipase D2 induces myocardial hypertrophy in Transgenic mice
    Kurz, Thomas
    Schaefer, Ulrich
    Joehren, Olaf
    Burgdorf, Christof
    CIRCULATION, 2007, 116 (16) : 247 - 247
  • [29] Transgenic overexpression of a mutation in murine cardiac troponin I results in cardiac hypertrophy and early lethality.
    James, J
    Zhang, S
    Osinska, H
    Klevitsky, R
    Hewett, T
    Sambe, A
    Robbins, J
    CIRCULATION, 1999, 100 (18) : 276 - 276
  • [30] Transgenic Knockdown of Cardiac Sodium/Glucose Cotransporter 1 (SGLT1) Attenuates PRKAG2 Cardiomyopathy, Whereas Transgenic Overexpression of Cardiac SGLT1 Causes Pathologic Hypertrophy and Dysfunction in Mice
    Ramratnam, Mohun
    Sharma, Ravi K.
    D'Auria, Stephen
    Lee, So Jung
    Wang, David
    Huang, Xue Yin N.
    Ahmad, Ferhaan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (04):
12345